Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug ...

Community Partnership Grants benefit nonprofit organizations that partner with Novartis and our associates for Community Partnership Day, as well as our other Company-sponsored volunteer programs ...

In April, Novartis AG announced that the US Food and Drug Administration (FDA) had approved manufacture of the drug (generic name, lutetium Lu 177 vipivotide tetraxetan injection) at a new facility in ...